138 related articles for article (PubMed ID: 34386769)
1. Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injections for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study.
Shridharani SM
Aesthet Surg J Open Forum; 2021 Sep; 3(3):ojab028. PubMed ID: 34386769
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Efficacy, Tolerability, and Outcomes of Topical Tripeptide/Hexapeptide Formulations Before and After Liposuction of the Medial Thighs.
Claytor B; Casas L; Ziegler M; Widgerow AD; Bell M
Aesthet Surg J Open Forum; 2021 Jan; 3(1):ojaa055. PubMed ID: 33791675
[TBL] [Abstract][Full Text] [Related]
3. Prospective, Randomized, Comparative Study of the Cutaneous Effects of a Topical Body Treatment Compared to a Bland Moisturizer.
Carruthers J; Bourne G; Bell M; Widgerow A
Aesthet Surg J; 2021 Aug; 41(9):NP1188-NP1198. PubMed ID: 33821935
[TBL] [Abstract][Full Text] [Related]
4. An Analysis of Patient-Reported Recovery Outcomes of Topical Tripeptide/Hexapeptide Formulations Utilized in a Prospective Randomized Double-Blind Split Neck and Body Study.
Casas LA; Bell M; Claytor B; Ziegler ME; Widgerow AD
Aesthet Surg J Open Forum; 2021 Jan; 3(1):ojaa052. PubMed ID: 33791673
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind trial evaluating the efficacy and tolerability of topical body treatment with TriHex Technology
Moradi A; Poehler J; Bell M
J Cosmet Dermatol; 2020 Mar; 19(3):677-681. PubMed ID: 32009299
[TBL] [Abstract][Full Text] [Related]
6. Deoxycholic Acid (ATX-101) for Reduction of Submental Fat.
Dunican KC; Patel DK
Ann Pharmacother; 2016 Oct; 50(10):855-61. PubMed ID: 27340142
[TBL] [Abstract][Full Text] [Related]
7. Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection.
Shridharani SM; Chandawarkar AA
Plast Reconstr Surg; 2019 Dec; 144(6):995e-1001e. PubMed ID: 31764639
[TBL] [Abstract][Full Text] [Related]
8. Early Experience in 100 Consecutive Patients With Injection Adipocytolysis for Neck Contouring With ATX-101 (Deoxycholic Acid).
Shridharani SM
Dermatol Surg; 2017 Jul; 43(7):950-958. PubMed ID: 28448317
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.
Ascher B; Hoffmann K; Walker P; Lippert S; Wollina U; Havlickova B
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1707-15. PubMed ID: 24605812
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Bilateral Submental Cryolipolysis With Quantified 3-Dimensional Imaging of Fat Reduction and Skin Tightening.
Bernstein EF; Bloom JD
JAMA Facial Plast Surg; 2017 Sep; 19(5):350-357. PubMed ID: 28426847
[TBL] [Abstract][Full Text] [Related]
11. Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.
Dover JS; Kenkel JM; Carruthers A; Lizzul PF; Gross TM; Subramanian M; Beddingfield FC
Dermatol Surg; 2016 Nov; 42 Suppl 1():S288-S299. PubMed ID: 27787269
[TBL] [Abstract][Full Text] [Related]
12. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study.
Rzany B; Griffiths T; Walker P; Lippert S; McDiarmid J; Havlickova B
Br J Dermatol; 2014 Feb; 170(2):445-53. PubMed ID: 24147933
[TBL] [Abstract][Full Text] [Related]
13. An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone.
Khan H; Ul Ain N; Bhatti DS; Khan J
Cureus; 2023 Feb; 15(2):e35286. PubMed ID: 36968884
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat.
Rotunda AM; Weiss SR; Rivkin LS
Dermatol Surg; 2009 May; 35(5):792-803. PubMed ID: 19397673
[TBL] [Abstract][Full Text] [Related]
15. A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections.
Walker P; Lee D
J Cosmet Dermatol; 2015 Mar; 14(1):33-9. PubMed ID: 25684122
[TBL] [Abstract][Full Text] [Related]
16. ATX-101 (deoxycholic acid injection) for reduction of submental fat.
Ascher B; Fellmann J; Monheit G
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1131-43. PubMed ID: 27457304
[TBL] [Abstract][Full Text] [Related]
17. A Multi-Center Evaluation of Restorative Eye Treatment and INhance With Trihex Technology to Improve Aesthetic Outcomes When Used Pre- and Post-Blepharoplasty.
Lee WW; Fagien S; Murdock J; Bell M; Widgerow AD
Aesthet Surg J Open Forum; 2023; 5():ojac089. PubMed ID: 36727033
[TBL] [Abstract][Full Text] [Related]
18. Quantifiable Changes in the Submental Area and Mandible Border After Dual-Modality Treatment With ATX-101 and VYC-20L for Overall Improvement in Jawline Contour.
Goodman GJ; Roberts S; Cook N; Ashton M; Nie R; Alker L; Silberberg M
J Drugs Dermatol; 2024 Jan; 23(1):1325-1331. PubMed ID: 38206149
[TBL] [Abstract][Full Text] [Related]
19. A Multicenter, Randomized, Double-Blind, Split-Body Clinical Trial Evaluating the Efficacy and Outcomes of a Topical Product Pre and Post Aesthetic Surgical Body Procedures.
Casas LA; Claytor RB; Zeidler KR; Shridharani SM; Cohen SR; Khanna JJ; Gould DJ; Yates EK; Lultschik S; Bell M; Widgerow AD
Aesthet Surg J Open Forum; 2022; 4():ojac054. PubMed ID: 35979375
[TBL] [Abstract][Full Text] [Related]
20. ATX-101 for reduction of submental fat: A phase III randomized controlled trial.
Humphrey S; Sykes J; Kantor J; Bertucci V; Walker P; Lee DR; Lizzul PF; Gross TM; Beddingfield FC
J Am Acad Dermatol; 2016 Oct; 75(4):788-797.e7. PubMed ID: 27430612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
